{"id":"https://openalex.org/W2440929631","doi":null,"title":"Overview of economic analysis of Le Chevalier Vinorelbine Study.","display_name":"Overview of economic analysis of Le Chevalier Vinorelbine Study.","publication_year":1998,"publication_date":"1998-03-01","ids":{"openalex":"https://openalex.org/W2440929631","mag":"2440929631","pmid":"https://pubmed.ncbi.nlm.nih.gov/9556778"},"language":"en","primary_location":{"id":"pmid:9556778","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9556778","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081792160","display_name":"Bruce E. Hillner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]},{"id":"https://openalex.org/I72019824","display_name":"Virginia Commonwealth University Medical Center","ror":"https://ror.org/057xmsr27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I72019824"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B E Hillner","raw_affiliation_strings":["Massey Cancer Center, Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massey Cancer Center, Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA","institution_ids":["https://openalex.org/I184840846","https://openalex.org/I4390039382","https://openalex.org/I72019824"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054848999","display_name":"Thomas J. Smith","orcid":"https://orcid.org/0000-0003-3040-6434","observed_orcids":["https://orcid.org/0000-0003-3040-6434"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T J Smith","raw_affiliation_strings":["Virginia Commonwealth University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Commonwealth University","institution_ids":["https://openalex.org/I184840846"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.8387,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.94084985,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"12","issue":"3 Suppl 4","first_page":"14","last_page":"6; discussion 17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8320000171661377},{"id":"https://openalex.org/keywords/vindesine","display_name":"vindesine","score":0.8009999990463257},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9449999928474426},{"id":"https://openalex.org/keywords/metastatic-lung-cancer","display_name":"metastatic lung cancer","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9300000071525574},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6169999837875366},{"id":"https://openalex.org/keywords/direct-medical-costs","display_name":"direct medical costs","score":0.5559999942779541},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6100000143051147},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.3970000147819519}],"concepts":[{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.9842507839202881},{"id":"https://openalex.org/C2779321808","wikidata":"https://www.wikidata.org/wiki/Q416660","display_name":"Vindesine","level":5,"score":0.8671448230743408},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6157810091972351},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.528969943523407},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.50003981590271},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.48594629764556885},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47795963287353516},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.47254300117492676},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.4456522762775421},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3626936376094818},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.32862389087677},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.0},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9556778","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9556778","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},{"id":"mag:2440929631","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9556778","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1917502393","https://openalex.org/W2061047185","https://openalex.org/W2128746268","https://openalex.org/W2129793485","https://openalex.org/W2276707897"],"related_works":["https://openalex.org/W2276707897","https://openalex.org/W96627920","https://openalex.org/W2033628360","https://openalex.org/W2153745838","https://openalex.org/W7096841296","https://openalex.org/W2169620790","https://openalex.org/W2460963867","https://openalex.org/W7064963362","https://openalex.org/W2395870018","https://openalex.org/W2350181934"],"abstract_inverted_index":{"The":[0],"costs":[1],"and":[2,37],"relative":[3],"cost-effectiveness":[4,88,149,209],"of":[5,65,79,89,138,144,151,155,165,170,176,190,195,201,210,229,237],"different":[6],"treatments":[7,16,28],"for":[8,17,62],"common":[9],"illnesses":[10],"are":[11,22,46],"an":[12,24,141,243],"increasing":[13],"concern.":[14],"New":[15],"advanced":[18],"non-small-cell":[19,67,95],"lung":[20,68,96],"cancer":[21,69,97],"having":[23],"impact.":[25],"However,":[26],"these":[27],"vary":[29],"markedly":[30],"in":[31,58,70,113,147],"their":[32],"direct":[33],"financial":[34],"costs,":[35],"toxicity,":[36],"quality-of-life":[38],"profiles.":[39],"Direct":[40],"comparisons":[41],"between":[42],"most":[43,123,219],"combination":[44],"regimens":[45,91],"not":[47],"yet":[48],"completed.":[49],"Vinorelbine":[50],"(Navelbine)":[51],"is":[52,226],"the":[53,59,63,86,109,122,207,211,234],"first":[54],"new":[55],"agent":[56],"approved":[57],"United":[60],"States":[61],"treatment":[64,112],"metastatic":[66],"more":[71],"than":[72,218],"a":[73,80,130,148,168,193],"decade.":[74],"We":[75,204],"previously":[76],"reported":[77],"results":[78],"post-hoc":[81],"economic":[82],"analysis":[83],"that":[84,117,206],"compared":[85],"anticipated":[87],"three":[90],"used":[92],"to":[93,180],"treat":[94],"(vinorelbine":[98],"alone":[99,128],"versus":[100,105],"vinorelbine":[101,118,127,132,184,212,225],"plus":[102,107,119,133,160,182,185,213],"cisplatin":[103,120,134,161,186,214,238],"[Platinol]":[104],"vindesine":[106,159,181],"cisplatin,":[108,183],"assumed":[110],"standard":[111],"Europe).":[114],"Results":[115],"showed":[116],"was":[121,216],"effective":[124],"regimen.":[125],"Using":[126],"as":[129],"baseline,":[131],"added":[135,162,187,239],"56":[136],"days":[137,164,189],"life":[139,156,166,177,191,202],"at":[140,167,192,242],"additional":[142,235],"cost":[143,169,194],"$2,700,":[145],"resulting":[146],"ratio":[150],"$17,700":[152],"per":[153,174,199],"year":[154,175,200],"gained.":[157,178,203],"Similarly,":[158],"19":[163],"$1,150,":[171],"or":[172,197],"$22,100":[173],"Compared":[179],"37":[188],"$1,570,":[196],"$15,500":[198],"conclude":[205],"incremental":[208],"regimen":[215],"less":[217],"commonly":[220],"accepted":[221],"medical":[222],"interventions.":[223],"If":[224],"preferred":[227],"because":[228],"its":[230],"favorable":[231],"toxicity":[232],"profile,":[233],"effectiveness":[236],"substantial":[240],"efficacy":[241],"acceptable":[244],"cost.":[245]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}